Minnesota group airs concerns over proposed 510(k) process changes

04/22/2010 | Star Tribune (Minneapolis-St. Paul, Minn.)

The Minnesota Medical Device Alliance said the proposed changes to the 510(k) process may require firms to conduct more clinical trials and delay product approvals. In a meeting with Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, the group called on the agency to retain the current regulatory framework while bolstering collaboration and communication with device makers.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
Boise, ID